PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting
1. PDSB's novel flu vaccine will be presented at IMMUNOLOGY2025. 2. PDSB advances cancer therapies, focusing on HPV16-positive cancers. 3. New NIH policies affect presentation of cancer therapy findings.